Glynos Nicolas G, Fields Christopher W, Barron Julie, Herberholz Moss, Kruger Daniel J, Boehnke Kevin F
Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Anesthesiology Department, University of Michigan Medical School, Ann Arbor, MI, USA.
J Psychoactive Drugs. 2023 Sep-Oct;55(4):379-388. doi: 10.1080/02791072.2022.2108356. Epub 2022 Aug 11.
Interest in and availability of psychedelics for therapeutic purposes has increased in recent decades. In a large, anonymous, online survey, we investigated patterns of communication with healthcare providers and awareness and utilization of substance testing kits or services among people using psychedelics naturalistically. The sample population included attendees of a psychedelic activism event and users of psychedelic social media forums. Among 1,435 participants, 72.5% never discussed psychedelic use with their primary care provider (PCP). Only 4.4% reported using psychedelics with a therapist and 3% in clinical settings, although 77.8% were very or extremely likely to take psychedelics with a therapist if one were legally available. While 62.6% of participants were aware of substance testing services, 42.6% of these indicated never using them. Regression analyses identified several variables associated with disclosure to PCP and utilization of substance testing services including age, gender, frequency and number of psychedelics used, and likelihood of consuming psychedelics under the guidance of a therapist if one were legally available. Further research is necessary to investigate these findings among other groups. Our findings suggest that relevant training and education for healthcare providers is needed, along with more visible options for substance identity testing.
近几十年来，人们对用于治疗目的的迷幻药的兴趣和可获得性有所增加。在一项大型匿名在线调查中，我们调查了自然使用迷幻药的人群与医疗服务提供者的沟通模式以及对药物检测试剂盒或服务的知晓度和使用情况。样本人群包括一次迷幻药激进主义活动的参与者和迷幻药社交媒体论坛的用户。在1435名参与者中，72.5%的人从未与他们的初级保健提供者（PCP）讨论过迷幻药的使用情况。只有4.4%的人报告说在治疗师的指导下使用迷幻药，3%的人在临床环境中使用，尽管如果法律允许，77.8%的人非常或极其可能在治疗师的指导下服用迷幻药。虽然62.6%的参与者知道药物检测服务，但其中42.6%的人表示从未使用过。回归分析确定了几个与向初级保健提供者披露信息以及药物检测服务使用情况相关的变量，包括年龄、性别、使用迷幻药的频率和数量，以及如果法律允许是否有可能在治疗师的指导下服用迷幻药。有必要在其他群体中对这些发现进行进一步研究。我们的研究结果表明，医疗服务提供者需要接受相关培训和教育，同时需要有更多明显的药物身份检测选项。
